410 related articles for article (PubMed ID: 34204886)
1. Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications.
van Harten AM; Brakenhoff RH
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204886
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition.
van Harten AM; de Boer DV; Martens-de Kemp SR; Buijze M; Ganzevles SH; Hunter KD; Leemans CR; van Beusechem VW; Wolthuis RMF; de Menezes RX; Brakenhoff RH
Sci Rep; 2020 Feb; 10(1):2330. PubMed ID: 32047167
[TBL] [Abstract][Full Text] [Related]
3. Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer.
Affolter A; Lammert A; Kern J; Scherl C; Rotter N
Front Cell Dev Biol; 2021; 9():666515. PubMed ID: 34307351
[TBL] [Abstract][Full Text] [Related]
4. Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck.
de Boer DV; Martens-de Kemp SR; Buijze M; Stigter-van Walsum M; Bloemena E; Dietrich R; Leemans CR; van Beusechem VW; Braakhuis BJM; Brakenhoff RH
Oncotarget; 2017 Nov; 8(58):97928-97940. PubMed ID: 29228663
[TBL] [Abstract][Full Text] [Related]
5. Novel genetic alterations and their impact on target therapy response in head and neck squamous cell carcinoma.
Jiang X; Ye J; Dong Z; Hu S; Xiao M
Cancer Manag Res; 2019; 11():1321-1336. PubMed ID: 30799957
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the evolution of premalignant lesions in the upper aerodigestive tract.
Lechner A; Kumbrink J; Walz C; Jung A; Baumeister P; Flach S
Front Oncol; 2024; 14():1364958. PubMed ID: 38706595
[TBL] [Abstract][Full Text] [Related]
7. Current Status of Human Papillomavirus-Targeted Therapies Development in Head and Neck Cancer.
Park JC; Bertaux B; Park J; Park S
JCO Precis Oncol; 2023 Jun; 7():e2300098. PubMed ID: 37315264
[TBL] [Abstract][Full Text] [Related]
8. Head and neck cancer: Current challenges and future perspectives.
Bhat GR; Hyole RG; Li J
Adv Cancer Res; 2021; 152():67-102. PubMed ID: 34353444
[TBL] [Abstract][Full Text] [Related]
9. Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma.
Choonoo G; Blucher AS; Higgins S; Boardman M; Jeng S; Zheng C; Jacobs J; Anderson A; Chamberlin S; Evans N; Vigoda M; Cordier B; Tyner JW; Kulesz-Martin M; McWeeney SK; Laderas T
PLoS One; 2019; 14(10):e0223639. PubMed ID: 31596908
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
Wilson HL; D'Agostino RB; Meegalla N; Petro R; Commander S; Topaloglu U; Zhang W; Porosnicu M
Oncologist; 2021 Feb; 26(2):e279-e289. PubMed ID: 33098199
[TBL] [Abstract][Full Text] [Related]
11. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
12. Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions.
Vitale-Cross L; Molinolo AA; Martin D; Younis RH; Maruyama T; Patel V; Chen W; Schneider A; Gutkind JS
Cancer Prev Res (Phila); 2012 Apr; 5(4):562-73. PubMed ID: 22467081
[TBL] [Abstract][Full Text] [Related]
13. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.
Starska-Kowarska K
Nutrients; 2023 May; 15(11):. PubMed ID: 37299554
[TBL] [Abstract][Full Text] [Related]
14. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.
Gadhikar MA; Sciuto MR; Alves MV; Pickering CR; Osman AA; Neskey DM; Zhao M; Fitzgerald AL; Myers JN; Frederick MJ
Mol Cancer Ther; 2013 Sep; 12(9):1860-73. PubMed ID: 23839309
[TBL] [Abstract][Full Text] [Related]
15. Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
Birkeland AC; Yanik M; Tillman BN; Scott MV; Foltin SK; Mann JE; Michmerhuizen NL; Ludwig ML; Sandelski MM; Komarck CM; Carey TE; Prince ME; Bradford CR; McHugh JB; Spector ME; Brenner JC
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):559-67. PubMed ID: 27077364
[TBL] [Abstract][Full Text] [Related]
16. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
17. The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma.
Cierpikowski P; Leszczyszyn A; Bar J
Cells; 2023 Aug; 12(16):. PubMed ID: 37626893
[TBL] [Abstract][Full Text] [Related]
18. Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death.
van Harten AM; Buijze M; van der Mast R; Rooimans MA; Martens-de Kemp SR; Bachas C; Brink A; Stigter-van Walsum M; Wolthuis RMF; Brakenhoff RH
Oncogenesis; 2019 Jun; 8(7):38. PubMed ID: 31209198
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy.
Canning M; Guo G; Yu M; Myint C; Groves MW; Byrd JK; Cui Y
Front Cell Dev Biol; 2019; 7():52. PubMed ID: 31024913
[TBL] [Abstract][Full Text] [Related]
20. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
Yang F; Zhou LQ; Yang HW; Wang YJ
Front Genet; 2022; 13():927614. PubMed ID: 36092911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
